ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,675Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 534

$1.25M Total Retail Price of All Prescriptions

Rank: 4 out of 534

514 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 1,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$129 was the average price of a prescription from this provider, compared to $110 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
TRAZODONE HCL 552 100 1 1
CYMBALTA 541 176 2 19
RISPERIDONE 458 97 3 2
SERTRALINE HCL 447 74 4 7
LAMOTRIGINE 417 12 5 6
CITALOPRAM HBR 391 126 6 3
BUPROPION HCL SR 374 80 7 10
ZOLPIDEM TARTRATE 354 35 8 13
QUETIAPINE FUMARATE 331 28 9 5
ABILIFY 295 0 10 9
AMPHETAMINE SALT COMBO 255 0 S2 11 26
VENLAFAXINE HCL ER 244 73 12 15
DIVALPROEX SODIUM ER 226 0 13 23
SUBOXONE 217 0 14 20
OLANZAPINE 215 34 15 11
BUSPIRONE HCL 203 49 16 22
BENZTROPINE MESYLATE 193 0 R 17 12
ESCITALOPRAM OXALATE 184 71 18 36
FLUOXETINE HCL 183 12 19 4
BUPROPION XL 182 47 20 29
CLONAZEPAM 156 121 21 46
MIRTAZAPINE 150 54 22 14
OXCARBAZEPINE 145 0 23 27
PAROXETINE HCL 143 0 24 21
METHYLPHENIDATE HCL 138 27 25 42
LITHIUM CARBONATE 118 19 26 16
SEROQUEL 117 11 27 25
AMITRIPTYLINE HCL 109 0 R 28 37
CLOZAPINE 107 0 29 8
LATUDA 105 0 30 57
LORAZEPAM 103 79 31 49
GABAPENTIN 100 28 32 17
TOPIRAMATE 96 0 33 31
ZIPRASIDONE HCL 82 0 34 35
DOXEPIN HCL 80 13 35 33
CLONIDINE HCL 79 0 36 24
DIVALPROEX SODIUM 67 14 37 18
LUNESTA 65 26 38 75
PERPHENAZINE 64 13 39 30
LEXAPRO 64 33 39 73
DONEPEZIL HCL 57 16 41 41
DEXTROAMPHETAMINE-AMPHETAMINE 53 0 S2 42 45
FLUVOXAMINE MALEATE 53 19 42 40
HYDROXYZINE PAMOATE 50 0 R 44 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.